α-L-Fucosidase: A Potential Biomarker for Differential Diagnosis of Autoimmune Hepatitis and Drug-Induced Autoimmune Hepatitis - 14/12/24
Doi : 10.1016/j.clinre.2024.102517
Yingying Lin a, 1, Xinyu Cui b, 1, Yanyan Li b, Na Zhu b, Xin Li a, ⁎ 
a Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, Beijing, China
b Department of Center of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China
⁎Corresponding author: Department of Center of Integrated Traditional Chinese and Western Medicine, Peking University Ditan Teaching Hospital, No. 8, Jingshun East Street, Chaoyang District, Beijing, 100015, ChinaDepartment of Center of Integrated Traditional Chinese and Western MedicinePeking University Ditan Teaching HospitalNo. 8, Jingshun East Street, Chaoyang DistrictBeijing100015China
Sous presse. Manuscrit accepté.
Disponible en ligne depuis le Saturday 14 December 2024
Highlights |
• | The extremely similar clinical features of AIH and DI-AIH make differentiating difficult. |
• | No method can effectively identify AIH and DI-AIH. |
• | α-l-fucosidase exhibits differential expression and diagnostic value between AIH and DI-AIH. |
• | The results of this study may inspire more relevant studies in the future. |
Keywords : Autoimmune hepatitis, Drug-induced autoimmune hepatitis, α-l-fucosidase, Diagnosis
Plan
© 2024
Publié par Elsevier Masson SAS.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?